Literature DB >> 30958743

Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.

Ashutosh K Tewari1, Bachir Taouli2,3, Stefanie J Hectors2,3, Mathew Cherny3, Kamlesh K Yadav1,4, Alp Tuna Beksaç1, Hari Thulasidass1, Sara Lewis2,3, Elai Davicioni5, Pei Wang6.   

Abstract

PURPOSE: We sought to 1) assess the association of radiomics features based on multiparametric magnetic resonance imaging with histopathological Gleason score, gene signatures and gene expression levels in prostate cancer and 2) build machine learning models based on radiomics features to predict adverse histopathological scores and the Decipher® genomics metastasis risk score.
MATERIALS AND METHODS: We retrospectively analyzed the records of 64 patients with prostate cancer with a mean age of 64 years (range 41 to 76) who underwent magnetic resonance imaging between January 2016 and January 2017 before radical prostatectomy. A total of 226 magnetic resonance imaging radiomics features, including histogram and texture features in addition to lesion size and the PI-RADS™ (Prostate Imaging Reporting and Data System) score, were extracted from T2-weighted, apparent diffusion coefficient and diffusion kurtosis imaging maps. Radiomics features were correlated with the pathological Gleason score, 40 gene expression signatures, including Decipher, and 698 prostate cancer related gene expression levels. Cross-validated, lasso regularized, logistic regression machine learning models based on radiomics features were built and evaluated for the prediction of Gleason score 8 or greater and Decipher score 0.6 or greater.
RESULTS: A total of 14 radiomics features significantly correlated with the Gleason score (highest correlation r = 0.39, p = 0.001). A total of 31 texture and histogram features significantly correlated with 19 gene signatures, particularly with the PORTOS (Post-Operative Radiation Therapy Outcomes Score) signature (strongest correlation r = -0.481, p = 0.002). A total of 40 diffusion-weighted imaging features correlated significantly with 132 gene expression levels. Machine learning prediction models showed fair performance to predict a Gleason score of 8 or greater (AUC 0.72) and excellent performance to predict a Decipher score of 0.6 or greater (AUC 0.84).
CONCLUSIONS: Magnetic resonance imaging radiomics features are promising markers of prostate cancer aggressiveness on the histopathological and genomics levels.

Entities:  

Keywords:  genomics; machine learning; magnetic resonance imaging; prostatectomy; prostatic neoplasms

Mesh:

Year:  2019        PMID: 30958743     DOI: 10.1097/JU.0000000000000272

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  The role of radiomics in prostate cancer radiotherapy.

Authors:  Rodrigo Delgadillo; John C Ford; Matthew C Abramowitz; Alan Dal Pra; Alan Pollack; Radka Stoyanova
Journal:  Strahlenther Onkol       Date:  2020-08-21       Impact factor: 3.621

2.  INTEGRATIVE RADIOMICS MODELS TO PREDICT BIOPSY RESULTS FOR NEGATIVE PROSTATE MRI.

Authors:  Haoxin Zheng; Qi Miao; Steven S Raman; Fabien Scalzo; Kyunghyun Sung
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2021-05-25

3.  Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI-pathology correlation and deep learning framework.

Authors:  Indrani Bhattacharya; Arun Seetharaman; Christian Kunder; Wei Shao; Leo C Chen; Simon J C Soerensen; Jeffrey B Wang; Nikola C Teslovich; Richard E Fan; Pejman Ghanouni; James D Brooks; Geoffrey A Sonn; Mirabela Rusu
Journal:  Med Image Anal       Date:  2021-11-06       Impact factor: 8.545

Review 4.  Overview of radiomics in prostate imaging and future directions.

Authors:  Hwan-Ho Cho; Chan Kyo Kim; Hyunjin Park
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

Review 5.  What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies.

Authors:  Rebeca Mirón Mombiela; Anne Rix Arildskov; Frederik Jager Bruun; Lotte Harries Hasselbalch; Kristine Bærentz Holst; Sine Hvid Rasmussen; Consuelo Borrás
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

6.  Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.

Authors:  Zine-Eddine Khene; Romain Mathieu; Benoit Peyronnet; Romain Kokorian; Anis Gasmi; Fares Khene; Nathalie Rioux-Leclercq; Solène-Florence Kammerer-Jacquet; Shahrokh Shariat; Brigitte Laguerre; Karim Bensalah
Journal:  World J Urol       Date:  2020-07-06       Impact factor: 4.226

7.  Development and head-to-head comparison of machine-learning models to identify patients requiring prostate biopsy.

Authors:  Shuanbao Yu; Jin Tao; Biao Dong; Yafeng Fan; Haopeng Du; Haotian Deng; Jinshan Cui; Guodong Hong; Xuepei Zhang
Journal:  BMC Urol       Date:  2021-05-16       Impact factor: 2.264

Review 8.  [MRI-guided minimally invasive treatment of prostate cancer].

Authors:  Fabian Tollens; Niklas Westhoff; Jost von Hardenberg; Sven Clausen; Michael Ehmann; Frank G Zöllner; Anne Adlung; Dominik F Bauer; Stefan O Schoenberg; Dominik Nörenberg
Journal:  Radiologe       Date:  2021-07-12       Impact factor: 0.635

9.  Integrative Machine Learning Prediction of Prostate Biopsy Results From Negative Multiparametric MRI.

Authors:  Haoxin Zheng; Qi Miao; Yongkai Liu; Steven S Raman; Fabien Scalzo; Kyunghyun Sung
Journal:  J Magn Reson Imaging       Date:  2021-06-23       Impact factor: 4.813

Review 10.  Artificial Intelligence Based Algorithms for Prostate Cancer Classification and Detection on Magnetic Resonance Imaging: A Narrative Review.

Authors:  Jasper J Twilt; Kicky G van Leeuwen; Henkjan J Huisman; Jurgen J Fütterer; Maarten de Rooij
Journal:  Diagnostics (Basel)       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.